SCHEMBL14745385

SCHEMBL14745385

CCc1ccc2cc(-c3[nH]c(=O)cc(O)c3CC)n(C)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 2/20 0.41
GPR84 Q9NQS5 4/20 0.36
TYMP P19971 1/20 0.33
MAPK14 Q16539 2/20 0.33
TRPA1 O75762 1/20 0.33
ALDH1A1 P00352 5/20 0.32
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
MAPT P10636 4/20 0.32
KDM4E B2RXH2 2/20 0.32
HPGD P15428 1/20 0.32
RECQL P46063 1/20 0.32
PLA2G10 O15496 1/20 0.31
PLA2G2A P14555 1/20 0.31
RAB9A P51151 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
CTDSP1 Q9GZU7 1/20 0.31
THRB P10828 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14746849 0.93 GPR84 (0.39) DAOGPR84ALDH1A1MEN1KMT2A
SCHEMBL14745614 0.91 DAO (0.39) DAOGPR84TYMPMAPK14TRPA1
SCHEMBL16428129 0.85 CA2 (0.43) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL14746133 0.84 GPR84 (0.39) DAOGPR84MAPK14MEN1KMT2A
SCHEMBL14746854 0.80 KDM4E (0.41) DAOMAPK14ALDH1A1MEN1KMT2A
SCHEMBL14745124 0.79 DAO (0.33) DAOALDH1A1KDM4E
SCHEMBL14745347 0.79 DAO (0.38) DAOALDH1A1MAPTPLA2G10PLA2G2A
SCHEMBL14741237 0.74 PDE9A (0.32) DAOGPR84ALDH1A1MEN1KMT2A
SCHEMBL16567889 0.71 CYP1A2 (0.36) GPR84ALDH1A1MAPTKDM4ERECQL
SCHEMBL14745213 0.70 PDE9A (0.37) DAOALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9409905-B2 Antibacterial compounds and methods for use PTC THERAPEUTICS, INC. (US) 2016-08-09 US disclosed
US-20150038437-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC THERAPEUTICS, INC. (US) 2015-02-05 US disclosed
EP-2750504-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC Therapeutics, Inc. (US) 2014-07-09 EP disclosed
WO-2013033258-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC THERAPEUTICS, INC. (US) 2013-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150038437-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE MRPL21, SLC11A2, CLPP DAO 558/4885GPR84 4656/4885TYMP 988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.